hydroxychloroquine has been researched along with iguratimod in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, C; Wu, R; Zheng, N | 1 |
| Ma, RR; Wu, F; Wu, TJ; Ying, ZH; Yu, JJ; Zhang, Y | 1 |
2 other study(ies) available for hydroxychloroquine and iguratimod
| Article | Year |
|---|---|
Iguratimod is effective in refractory rheumatoid arthritis patients with inadequate response to methotrexate-cyclosporin A-hydroxychloroquine-prednisone.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Chromones; Cyclosporine; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Prednisone; Retrospective Studies; Sulfonamides; Treatment Outcome | 2018 |
The effects of iguratimod combined with methotrexate and hydroxychloroquine on bone mineral density in patients with rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Bone Density; Chromones; Drug Therapy, Combination; Humans; Hydroxychloroquine; Methotrexate; Retrospective Studies; Sulfonamides | 2021 |